Mirjam C. Boelens Sign in to save

OpenAlex profile details not fetched

–

Citations

–

h-index

–

i10-index

–

Works (all)

Aachen papers

Departments & institutes in Aachen

No department could be parsed from this author's affiliation strings.

Affiliations exactly as printed on papers (7)

5× Department of Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands
1× Pathology, Netherlands Cancer Institute, Amsterdam, Netherlands
1× Department of Pathology, Antoni van Leeuwenhoek Hospital, Netherlands Cancer Institute, Amsterdam, The Netherlands
1× Department of Pathology, Netherlands Cancer Institute , Amsterdam ,
1× Department of Pathology, Netherlands Cancer Institute, The Netherlands
1× Department of Pathology, The Netherlands Cancer Institute (NKI), Amsterdam, The Netherlands
1× Netherlands Cancer Institute, Antoni van Leeuwenhoekziekenhuis, Amsterdam/NL

Papers 11 stored

All · Aachen affiliation only

Author Correction: Real-world clinical utility of tumor whole-genome sequencing in solid cancers
2026 Nature Medicine erratum Biochemistry, Genetics and Molecular Biology Cancer Genomics and Diagnostics Open access

0

citations
Real-world clinical utility of tumor whole-genome sequencing in solid cancers
2026 Nature Medicine article Biochemistry, Genetics and Molecular Biology Cancer Genomics and Diagnostics Open access

11

citations
Longitudinal Circulating Tumor DNA–Guided Resistance Analysis During Second-Line Osimertinib Treatment
2025 JTO Clinical and Research Reports article Medicine Lung Cancer Treatments and Mutations Open access

1

citations
Combined analysis of circulating tumor DNA and tumor tissue to overcome osimertinib resistance (OSIRIS); the second line osimertinib cohort
2024 Lung Cancer article Medicine Lung Cancer Treatments and Mutations Open access

5

citations
1262P Combined molecular analysis of circulating tumour DNA and tumour tissue to identify osimertinib resistance
2024 Annals of Oncology article Medicine Lung Cancer Treatments and Mutations Open access

0

citations
Osimertinib-induced DNA resistance mutations in cerebrospinal fluid of epidermal growth factor receptor-mutated non-small-cell lung carcinoma patients developing leptomeningeal metastases: Osimertinib Resistance Analysis-leptomeningeal metastases study
2024 Neuro-Oncology article Medicine Lung Cancer Treatments and Mutations Open access

11

citations
P2.10-07 ORA-LM: Molecular Analysis in Cerebrospinal Fluid of ALK or EGFR Positive NSCLC Patients with Leptomeningeal Metastases
2023 Journal of Thoracic Oncology article Medicine Lung Cancer Treatments and Mutations Open access

0

citations
Trastuzumab-Emtansine and Osimertinib Combination Therapy to Target HER2 Bypass Track Resistance in EGFR Mutation-Positive NSCLC
2023 JTO Clinical and Research Reports article Medicine Lung Cancer Treatments and Mutations Open access

24

citations
Real-World Approach for Molecular Analysis of Acquired EGFR Tyrosine Kinase Inhibitor Resistance Mechanisms in NSCLC
2021 JTO Clinical and Research Reports article Medicine Lung Cancer Treatments and Mutations Open access

8

citations
RET Fluorescence In Situ Hybridization Analysis Is a Sensitive but Highly Unspecific Screening Method for RET Fusions in Lung Cancer
2021 Journal of Thoracic Oncology article Medicine Lung Cancer Treatments and Mutations Open access

42

citations
Multicenter Comparison of Molecular Tumor Boards in The Netherlands: Definition, Composition, Methods, and Targeted Therapy Recommendations
2020 The Oncologist article Biochemistry, Genetics and Molecular Biology Cancer Genomics and Diagnostics Open access

51

citations

11 results

Mirjam C. Boelens ▲ Sign in to save

Departments & institutes in Aachen

Papers 11 stored

Mirjam C. Boelens Sign in to save